These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14674374)

  • 1. PLT transfusions from D+ blood donors to D-patients with hematologic diseases: am update.
    Cid J
    Transfusion; 2003 Dec; 43(12):1759-60. PubMed ID: 14674374
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis for D- patients receiving platelet transfusions from D+ [correction of D-] donors?
    Menitove JE
    Transfusion; 2002 Feb; 42(2):136-8. PubMed ID: 11896325
    [No Abstract]   [Full Text] [Related]  

  • 3. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases.
    Lichtiger B; Surgeon J; Rhorer S
    Vox Sang; 1983; 45(2):139-43. PubMed ID: 6412457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J; Ortin X; Elies E; Castellà D; Panadés M; Martín-Vega C
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M; Cid J
    Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets.
    Molnar R; Johnson R; Sweat LT; Geiger TL
    Transfusion; 2002 Feb; 42(2):177-82. PubMed ID: 11896332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
    Asfour M; Narvios A; Lichtiger B
    MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Rh (D) alloimmunisation after Rh (D) positive platelet transfusions in patients undergoing haematopoietic stem cell transplantation.
    Solves P; Carpio N; Gómez I; Hernani R; Sanz GF; Sanz MA
    Transfus Med; 2015 Feb; 25(1):49-50. PubMed ID: 25737308
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness.
    Mishima Y; Tsuno NH; Matsuhashi M; Yoshizato T; Sato T; Ikeda T; Watanabe-Okochi N; Nagura Y; Sone S; Kurokawa M; Okazaki H
    Transfus Apher Sci; 2015 Feb; 52(1):112-21. PubMed ID: 25467707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation using donor-specific blood transfusions despite Rh incompatibility.
    Schweizer RT; Bartus SA; Silver H; McLean RH
    Transplantation; 1981 Oct; 32(4):345-7. PubMed ID: 6800079
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prophylactic platelet transfusion in patients with hematologic diseases].
    Siitonen T; Koistinen P
    Duodecim; 2004; 120(7):877-84. PubMed ID: 15154309
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens.
    Saito S; Ota S; Seshimo H; Yamazaki Y; Nomura S; Ito T; Miki J; Ota M; Fukushima H; Maeda H
    Transfusion; 2002 Mar; 42(3):302-8. PubMed ID: 11961234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies.
    Maurer-Spurej E; Labrie A; Pittendreigh C; Chipperfield K; Smith C; Heddle N; Liu Y; Yi QL; Barnett M
    Transfusion; 2009 Nov; 49(11):2276-84. PubMed ID: 19903289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients.
    Cid J; Carbassé G; Pereira A; Sanz C; Mazzara R; Escolar G; Lozano M
    Transfusion; 2011 Jun; 51(6):1163-9. PubMed ID: 21126258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases.
    Cid J; Lozano M; Fernández-Avilés F; Carreras E; Pereira A; Mazzara R; Ordinas A
    Transfusion; 2006 Feb; 46(2):169-73. PubMed ID: 16441590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.
    Seager A; Sandler SG
    Immunohematology; 2013; 29(3):110-4. PubMed ID: 24325172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.